Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.01% |
| 2 | Technology | 7.76% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 7.12% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
St. Joe Company
JOE
$3.83B
| $4.98M | ﹤0.01% |
125,872
+114,807
| +1,038% | +$5.72M |
|
2777
Revolution Medicines
RVMD
$44.6B
| $4.98M | ﹤0.01% |
255,443
+231,670
| +975% | +$4.51M |
|
|
AGEN
2778
Agenus
AGEN
$345M
| $4.97M | ﹤0.01% |
130,558
-161,489
| -55% | -$5.86M |
|
2779
Liquidia Corp
LQDA
$6.06B
| $4.96M | ﹤0.01% |
1,137,885
-402,639
| -26% | -$2.08M |
|
2780
State Street SPDR S&P Retail ETF
XRT
$322M
| $4.96M | ﹤0.01% |
85,288
+608
| +0.7% | +$41.4K |
|
2781
Reynolds Consumer Products
REYN
$5.07B
| $4.95M | ﹤0.01% |
181,472
+161,253
| +798% | +$4.52M |
|
|
CIXX
2782
DELISTED
CI Financial Corp.
CIXX
| $4.95M | ﹤0.01% |
465,860
+159,363
| +52% | +$2.02M |
|
2783
Vanguard Morningstar Value ETF
VTV
$192B
| $4.94M | ﹤0.01% |
37,446
-1,822
| -5% | -$257K |
|
2784
Immatics
IMTX
$1.44B
| $4.94M | ﹤0.01% |
566,752
+529,325
| +1,414% | +$4.19M |
|
2785
Aldeyra Therapeutics
ALDX
$89.9M
| $4.93M | ﹤0.01% |
1,236,752
+732,290
| +145% | +$2.52M |
|
2786
NNN REIT
NNN
$8.77B
| $4.93M | ﹤0.01% |
114,767
-317,166
| -73% | -$14M |
|
2787
CALL
Rogers Communications
RCI
$19.8B
| $4.93M | ﹤0.01% |
80,000
| – | – |
|
|
2788
PUT
Rogers Communications
RCI
$19.8B
| $4.93M | ﹤0.01% |
80,000
| – | – |
|
|
KRTX
2789
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $4.93M | ﹤0.01% |
+39,000
| New | +$4.48M |
|
2790
Southland Holdings
SLND
$35.6M
| $4.93M | ﹤0.01% |
496,991
+296,961
| +148% | +$2.95M |
|
|
AKRO
2791
DELISTED
Akero Therapeutics
AKRO
| $4.92M | ﹤0.01% |
520,769
+455,525
| +698% | +$4.75M |
|
2792
Landstar System
LSTR
$6.11B
| $4.92M | ﹤0.01% |
33,822
-22,140
| -40% | -$3.3M |
|
|
CYBR
2793
DELISTED
CyberArk
CYBR
| $4.91M | ﹤0.01% |
38,337
+25,704
| +203% | +$3.71M |
|
2794
Voyager Therapeutics
VYGR
$218M
| $4.9M | ﹤0.01% |
828,796
+646,814
| +355% | +$4.37M |
|
2795
Trimble
TRMB
$14.2B
| $4.89M | ﹤0.01% |
84,070
-344,653
| -80% | -$22.6M |
|
|
FYBR
2796
DELISTED
Frontier Communications
FYBR
| $4.89M | ﹤0.01% |
207,851
-1,180,042
| -85% | -$30.2M |
|
2797
CALL
iShares MSCI Taiwan ETF
EWT
$11.7B
| $4.89M | ﹤0.01% |
+97,000
| New | +$5.4M |
|
|
AZEK
2798
DELISTED
The AZEK Co
AZEK
| $4.89M | ﹤0.01% |
292,115
-250,808
| -46% | -$5.15M |
|
2799
Stellantis
STLA
$20.4B
| $4.89M | ﹤0.01% |
395,296
-484,701
| -55% | -$6.85M |
|
|
MFA
2800
MFA Financial
MFA
$893M
| $4.88M | ﹤0.01% |
453,971
-389,106
| -46% | -$5.24M |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $8.78B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 60% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.